Loading…

Bausch + Lomb has made an equity investment in Sanoculis and signed an exclusive European distribution agreement for the MIMS® minimally invasive glaucoma treatment.
“Bausch + Lomb has made an equity investment in Sanoculis and signed an exclusive European distribution agreement for the MIMS® glaucoma treatment.”stocktitan.net
Summarized from public sources; check the original articles before acting on it.